Drug Invest Information

Pharmaceuticals
Johnson & Johnson Targets FDA Approval for Groundbreaking gMG Drug Amidst Fierce Competition Aug 30, 2024
Companies
Intelligent Bio Solutions Inc. Addresses the Escalating Demand for Workplace Drug Testing Solutions Aug 14, 2024
Companies
Immix Biopharma Receives EU Orphan Drug Designation for NXC-201 in Multiple Myeloma Apr 29, 2024
Pharmaceuticals
SpringWorks Therapeutics Begins Rolling NDA Submission for NF1-PN Treatment Mar 5, 2024
Companies
MindMed's Strategic Shift in 2024: Focusing on Anxiety Treatments and Halting LSD Microdosing for ADHD Jan 11, 2024
Pharmaceuticals
AstraZeneca AZN Cancels Two Key Phase III Trials for Hyperkalemia Drug Lokelma Dec 2, 2023
Investment
SciSparc Ltd. Embarks on Transformative Phase IIb Trial for Tourette Syndrome Using THC-Based Medication Nov 11, 2023
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin Nov 9, 2023